Press release
2019-2034 Global CNS Therapeutics Market Report & Insights
CNS Therapeutics Market Analysis 2019-2034 Report
In 2024, North America led the market with revenue of approximately USD 49.6 billion, followed by Europe at USD 31.0 billion. The Asia Pacific region recorded USD 25.1 billion and is the fastest growing with a CAGR of 8.80% from 2025 to 2034. Latin America and Middle East & Africa contributed USD 11.3 billion and USD 6.4 billion respectively in 2024. Regional growth is driven by rising healthcare expenditure and improved access to specialized treatments.
Mental health indications constituted the largest disease segment with USD 32.3 billion in 2024, followed by neurovascular diseases at USD 23.7 billion. Neurodegenerative diseases and CNS cancer segments generated USD 21.0 billion and USD 15.2 billion respectively. CNS trauma and infectious diseases accounted for USD 12.6 billion and USD 10.0 billion. CNS cancer is set to expand fastest with a CAGR of 8.72% over the forecast period, while contagious conditions show more moderate growth.
Among drug classes, anesthetics held a significant portion at USD 17.6 billion in 2024. Anticonvulsants followed closely with USD 16.1 billion. CNS stimulants posted USD 24.0 billion and are expected to register the highest CAGR of 8.83% from 2025 to 2034. Pain relievers and antiemetics contributed USD 38.3 billion and USD 12.9 billion respectively. The "others" category, covering specialized formulations, reached USD 14.5 billion in 2024.
In 2024, hospital pharmacies generated USD 59.4 billion in revenue, making them the dominant distribution channel. Retail pharmacies followed at USD 48.0 billion, supported by growing outpatient care. The "others" segment, including online and institutional sales, accounted for USD 16.0 billion. The fastest growth is seen in the "others" channel with a CAGR of 8.63% through 2034, reflecting digitalization and alternative supply models in drug distribution.
By 2034, North America is expected to exceed USD 98.1 billion and Europe will approach USD 62.5 billion. The Asia Pacific market could surpass USD 57.9 billion, driven by improving healthcare infrastructure. Latin America may reach USD 23.7 billion and Middle East & Africa USD 14.0 billion. These regions will benefit from demographic shifts and government initiatives, ensuring a balanced global market expansion across developed and emerging economies.
Looking ahead, mental health is projected to reach USD 70.2 billion by 2034 and neurodegenerative diseases USD 44.4 billion. Neurovascular conditions are set to climb to USD 47.9 billion and CNS cancer to USD 34.7 billion. CNS trauma and infectious diseases will rise to USD 24.5 billion and USD 19.1 billion respectively. These trends underscore sustained investment in neurology and growing demand for innovative therapies.
By 2034, anesthetics may exceed USD 29.9 billion and anticonvulsants USD 35.2 billion. CNS stimulants could grow to USD 55.6 billion and pain relievers to USD 81.5 billion, reflecting sustained demand for symptom management. Antiemetics are forecast to reach USD 24.8 billion. The combined "others" segment will approach USD 29.2 billion, highlighting niche therapies and personalized medicine as areas of lucrative growth.
By 2034, hospital pharmacies are anticipated to record USD 130.8 billion, while retail pharmacies could reach USD 89.1 billion. Alternative channels, including online platforms and institutional procurement, may grow to USD 36.3 billion. The robust expansion of digital sales and evolving healthcare delivery models will continue to reshape distribution dynamics, offering new opportunities for market entrants and established players alike.
Key players in the Global CNS Therapeutics Market include Pfizer Inc., Novartis AG, Johnson & Johnson, Roche Holding AG, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., Biogen Inc., Otsuka Pharmaceutical Co., Ltd., and Lundbeck A/S. These companies lead through robust pipelines, strategic alliances, and investment in research and development. Their portfolios span small molecules, biologics, and advanced therapies targeting diverse CNS conditions, reinforcing their competitive positions in this growing market.
Market growth is driven by rising prevalence of neurological disorders, aging populations, and increased mental health awareness. Innovation in gene therapies, biologics, and novel small molecules is accelerating product pipelines. Regulatory support and reimbursement policies in developed economies enhance market uptake. The expansion of contract research and manufacturing services further supports faster time to market. Collaboration between academia and industry is fostering personalized and precision medicine approaches in CNS therapy development.
Read the full report description here: https://globaldatarouteanalytics.com/report/11/globalcnstherapeuticsmarketsegmentskeyplayers2025
For a free sample report, click the link below
https://globaldatarouteanalytics.com/contact
Visit our website: https://globaldatarouteanalytics.com/
Global Data Route Analytics
Kumar Complex
Pali Road, Dehri-on-Sone Rohtas,
Bihar 821307
Email: sales@globaldatarouteanalytics.com
Global Data Route Analytics is a premier business intelligence and consulting firm committed to delivering insightful market research and strategic guidance to businesses worldwide.
Our team of seasoned analysts and consultants specializes in providing comprehensive market research reports, tailored consulting services, and customized research planning solutions.
We pride ourselves on adhering to rigorous methodologies, leveraging cutting-edge technology, and maintaining an unwavering focus on client satisfaction. By transforming complex data into actionable insights, we empower our clients to make informed decisions, capitalize on opportunities, and achieve sustained success in an increasingly competitive landscape
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2019-2034 Global CNS Therapeutics Market Report & Insights here
News-ID: 4096607 • Views: …
More Releases from Global Data Route Analytics
Ceramic 3D Printing Market Resets Expectations, May See Boost in Revenue Cycle
Latest Report Available at Global Data Route Analytics," Ceramic 3D Printing Market" provides pin-point analysis for changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
Introduction
Market Snapshot: The global ceramic 3D printing market is expected to grow from around USD 290 million in 2024 to nearly USD 3.6 billion by 2034, achieving a strong CAGR of 27.8% during the forecast period.
Key Growth Drivers: Rising demand…
Graphene Composites Market Outlook: Know What Factors Suggest Great Pickup in Mo …
Latest Report Available at Global Data Route Analytics," Graphene Composites Market" provides pin-point analysis for changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
Introduction
Market Overview: The global graphene composites market is projected to grow from USD 27.8 million in 2025 to around USD 145.6 million by 2031, demonstrating a remarkable CAGR of 33.8% over the forecast period.
Growth Drivers: Rising demand for lightweight, high-strength, and…
Polymer Coatings Market Is Likely to Experience a Tremendous Growth in Near Futu …
Latest Report Available at Global Data Route Analytics," Polymer Coatings Market" provides pin-point analysis for changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
Introduction
Market Overview: The global polymer coatings market is poised for significant growth, valued at approximately $9.8 billion in 2025 and expected to reach $17.5 billion by 2031, reflecting a steady CAGR of 6.0% during the forecast period.
Growth Drivers: Increasing demand for…
Liquid Alloys Market Expectation Surges with Rising Demand and Changing Trends
Latest Report Available at Global Data Route Analytics," Liquid Alloys Market" provides pin-point analysis for changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
Introduction
Market Size and Forecast: The global liquid alloys market is set to witness significant growth, with its value expected to increase from approximately USD 207.8 million in 2024 to over USD 367.4 million by 2032, reflecting rising demand across various industrial…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
